WallStreetZenWallStreetZen

NASDAQ: CGON
Cg Oncology Inc Stock Ownership - Who owns Cg Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cg Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Leonard E. PostDirector2025-05-211,000$0.60
$600.00Buy
Leonard E. PostDirector2025-05-211,000$28.00
$28.00kSell
Leonard E. PostDirector2025-04-281,000$0.60
$600.00Buy
Leonard E. PostDirector2025-04-281,000$30.76
$30.76kSell
Leonard E. PostDirector2025-03-171,000$28.00
$28.00kSell
Leonard E. PostDirector2025-03-171,000$0.60
$600.00Buy
Leonard E. PostDirector2025-02-181,000$0.60
$600.00Buy
Leonard E. PostDirector2025-02-181,000$28.61
$28.61kSell
Leonard E. PostDirector2025-01-131,000$29.66
$29.66kSell
Leonard E. PostDirector2025-01-131,000$0.60
$600.00Buy

1 of 2

CGON insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CGON insiders and whales buy or sell their stock.

CGON Shareholders

What type of owners hold Cg Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Decheng Capital LLC8.36%6,371,669$164.77MInstitution
Vanguard Group Inc7.66%5,836,320$150.93MInstitution
Decheng Capital Global Life Sciences Fund IV LP7.03%5,358,810$138.58MInsider
Blackrock Inc5.71%4,355,060$112.62MInstitution
Hong Fang Song5.52%4,204,841$108.74MInsider
Tcg Crossover Management LLC4.81%3,670,206$94.91MInstitution
Braidwell LP4.31%3,283,317$84.91MInstitution
Kynam Capital Management LP3.43%2,611,662$67.54MInstitution
Fmr LLC3.34%2,545,098$65.82MInstitution
Orbimed Advisors LLC3.24%2,471,994$63.93MInstitution

1 of 3

CGON vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CGON88.05%11.95%Net SellingNet Buying
AGIO75.68%24.32%Net SellingNet Selling
IDYA92.55%7.45%Net Buying
RXRX74.85%17.15%Net SellingNet Selling
BLTE0.47%0.00%
View Top Biotech Stocks

Cg Oncology Stock Ownership FAQ

Who owns Cg Oncology?

Cg Oncology (NASDAQ: CGON) is owned by 92.83% institutional shareholders, 12.60% Cg Oncology insiders, and 0.00% retail investors. Decheng Capital Global Life Sciences Fund IV LP is the largest individual Cg Oncology shareholder, owning 5.36M shares representing 7.03% of the company. Decheng Capital Global Life Sciences Fund IV LP's Cg Oncology shares are currently valued at $138.58M.

If you're new to stock investing, here's how to buy Cg Oncology stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.